CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale General Counsel & Corp. Sec'y sold 4,755 shares at $17.55 ($83,450)
- 4 Planned sale General Counsel & Corp. Sec'y sold 12,778 shares at $18.01 ($230,120)
- 4 Planned sale Chief Medical Officer sold 22,321 shares at $18.01 ($401,981)
- 4 Planned sale Chief Business Officer sold 17,937 shares at $18.01 ($323,029)
- 4 Planned sale Chief Financial Officer sold 19,771 shares at $18.01 ($356,058)
- 4 Planned sale President and CEO sold 70,150 shares at $18.01 ($1,263,338)
- 4 Grant or award General Counsel & Corp. Sec'y acquired 27,187 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 43,750 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 35,156 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 38,750 shares (grant or award)
- 4 Grant or award President and CEO acquired 137,500 shares (grant or award)
- 4 Option exercise Chief Financial Officer acquired 30,750 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 5,800 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 11 · 215 filings